Andrew G. Horti
Division of Nuclear Medicine
Department of Radiology
Johns Hopkins Medical Institutions
600 North Wolfe Street
USA
Name/email consistency: high
- Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2). Horti, A.G., Gao, Y., Ravert, H.T., Finley, P., Valentine, H., Wong, D.F., Endres, C.J., Savonenko, A.V., Dannals, R.F. Bioorg. Med. Chem. (2010)
- Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography. Horti, A.G., Gao, Y., Kuwabara, H., Dannals, R.F. Life Sci. (2010)
- Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain. Horti, A.G., Van Laere, K. Curr. Pharm. Des. (2008)
- 11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors. Horti, A.G., Fan, H., Kuwabara, H., Hilton, J., Ravert, H.T., Holt, D.P., Alexander, M., Kumar, A., Rahmim, A., Scheffel, U., Wong, D.F., Dannals, R.F. J. Nucl. Med. (2006)
- The quest for Eldorado: development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain. Horti, A.G., Villemagne, V.L. Curr. Pharm. Des. (2006)